Table 1. Different Hematological Indices Observed As Per Treatment Groups during the Study^a.

parameters	control group (I)	control + camel milk group (II)	diabetic control group (III)	insulin group (IV)	camel milk group (V)	camel milk + insulin group (VI)
hemoglobin (Hb) g/dL	14.9 ± 0.90	15.0 ± 0.84	10.6 ± 0.58b	14.4 ± 0.57c	14.6 ± 0.99c	14.0 ± 1.19c
total leukocyte count (TLC)/cumm	12850 ± 446.09	10566.6 ± 1665.73b	5550 ± 766.15b	9766.6 ± 1481.44c	10016.6 ±1302.94c	9450 ± 589.06c
neutrophil (%)	22.1 ± 1.47	20.3 ± 1.03	17.1 ± 2.31b	26.6 ± 4.80c	25 ± 0.894c	24 ± 2.09c
lymphocytes (%)	74.5 ± 5.00	74.8 ± 1.72	65 ± 1.41b	71.6 ± 3.82c	74.1 ± 2.85c	72.6 ± 3.38c
eosinophil (%)	1 ± 0	1 ± 0	1 ± 0	1 ± 0	1 ± 0	1.3 ± 0.51
monocyte (%)	1 ± 0	1.3 ± 0.51	1.1 ± 0.40	1.6 ± 0.51	1 ± 0	1.8 ± 0.98
basophil (%)	0	0	0	0	0	0.1 ± 0.40
RBC count (millions/cmm)	8.9 ± 0.544	8.1 ± 0.96	5.5 ± 0.79b	8.4 ± 0.76c	8.4 ± 0.66c	8.1 ± 0.73c
PCV (%)	54.5 ± 1.44	50.0 ± 1.65	35.8 ± 2.33b	53.9 ± 3.62c	53.5 ± 2.58c	52.1 ± 2.66c
MCV (fl.)	56.9 ± 1.49	54.8 ± 3.96	42.4 ± 4.85b	62.5 ± 4.86c	56.5 ± 1.84c	52.2 ± 1.54c
MCH pictogram	20.5 ± 1.39	18.9 ± 1.38	15.5 ± 0.59b	18.1 ± 0.95c	18.3 ± 1.23c	18.3 ± 1.02c
MCHC (gm/dL)	39.3 ± 2.60	40.1 ± 4.59	23.0 ± 1.55b	36.5 ± 3.36c	36.6 ± 3.61c	35.5 ± 3.16c
platelet count (lakh/cmm)	6.0 ± 2.12	5.41 ± 0.77	3.1 ± 1.06b	3.6 ± 0.84	3.3 ± 0.99	8.7 ± 0.66c,d

^aData are presented as mean ± SD; N = 6. Abbreviations: RBC = red blood cells; PCV = packed cell volume; MCV = mean corpuscular volume; MCH = mean corpuscular hemoglobin; MCHC = mean corpuscular hemoglobin concentration; values are significant at 5% for ANOVA.

^bRepresents significance in comparison to control.

^cRepresents significance in comparison to diabetic control.

^dRepresents significance in comparison to camel milk (P value represented with * # $ < 0.05).